- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Sickle Cell Disease Treatment Market is expected to reach US$ 4,691.87 million by 2030
Nov 07, 2023
US Pharmacy Management System Market is expected to reach US$ 53,139.59 million by 2030
Sep 21, 2023
Aphria Inc Launches Plant Positivity Social Impact Platform with Evergreen
Sep 19, 2019
Non-Gelatin Empty Capsules Market is expected to reach US$ 4.64 billion by 2030
Feb 14, 2024
Asia Pacific Transdermal Drug Delivery System Market Prospects & Upcoming Trends and Opportunities Upto 2027
Sep 05, 2020
North America Intravenous Immunoglobulin Market is expected to reach US$ 8,747.81 million by 2030
Oct 10, 2023
Vaccine Adjuvant Market is expected to reach US$ 6,931.55 million by 2030
Jan 09, 2024
Follow us on
